Xcout IntelATEM Capital
ATEM Capital is a venture capital firm that invests in life sciences innovations, focusing on breakthrough technologies with unmet clinical need and strong intellectual property protection. The firm partners with venture capital groups in the US and EU to invest in biotechnology and pharmaceutical companies developing treatments for diseases such as cancer, rare disorders, and viral infections.
Subscribe to see ATEM Capital’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ATEM Capital at a glance
ATEM Capital is a venture capital and private equity company headquartered in United States. Xcout tracks 12 named people at ATEM Capital, including Allan Gobbs (Managing Partner).
ATEM Capital leadership
- Allan GobbsManaging Partner
- Dmitry KobyzevManaging Partner
- Elena MaleyManaging Partner
- Ilya YasnyManaging Partner
- Ed GodberMBA
- Ilia ArdabevskiiPrincipal
6 more named people on record for ATEM Capital, with roles, board committees and tenure — see the full roster →
ATEM Capital competitors
A few of ATEM Capital's closest competitors — see the full list of competitors and alternatives →
AdBio Partners is a venture capital firm that invests in and develops early-stage life sciences and biotech startups across Europe. The company partners with academic institutions and scientific founders to fund breakthrough medical discoveries and therapeutic innovations.
BioMed Partners (BiomedVC) is a venture capital firm that invests in early-stage life science startups in continental Europe, with a focus on Switzerland and Germany. The firm provides initial investments at the Seed and Series A stages to help entrepreneurs translate academic scientific innovations into venture-backed biotech companies developing therapeutics for high-unmet medical needs.
TVM Capital Life Science is a venture capital firm that invests in life science innovations, including early-stage therapeutics, commercial-stage medtech, diagnostics, and digital health products. The firm provides capital and expertise to portfolio companies in North America and Europe to help bring new therapies and medical products to market.
Atma Capital is an investment firm that partners with founders to fund companies focused on health, technology, and biotechnology. Its investment portfolio includes businesses developing at-home health diagnostics, anti-aging science, AI-driven athletic performance, programmable mRNA therapeutics, vision care technology, and cancer treatments.
Alta Partners is a healthcare venture capital firm that invests in and partners with entrepreneurs to build high-impact life sciences and biotechnology companies. The firm supports businesses focused on developing novel therapeutics, medical technologies, and healthcare delivery platforms.
Agent Capital is a healthcare venture capital firm that invests in novel therapeutics and treatments across various stages of development to address unmet patient needs. The firm partners with scientists and entrepreneurs, guiding biotechnology companies toward key milestones and exits.
Get ATEM Capital's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about ATEM Capital? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ATEM Capital in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access